When compared with other Alzheimer’s disease biomarkers such as CSF-based amyloid and tau markers, or PET markers, brain-age provided an independent contribution in identifying people who convert from mild cognitive impairment to Alzheimer’s disease (Popescu et al., 2020). Here, MAPT is linked to Alzheimer disease.